Universe Pharmaceuticals Inc (UPC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.93-5.30%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$9.0M

Revenue YoY

-34.7%

Net profit

$-1.6M

Net margin

-17.2%

Market cap

$20.9M

Forward P/E

0.0

P/B

0.42

Book value

$98.78

EPS (TTM)

$-1.37

52-week high

$17.96

52-week low

$2.00

50-day MA

$4.86

200-day MA

$3.88

Beta

1.68

Insiders

88.82%

Institutions

2.25%

Fund	Stake
HRT FINANCIAL LLC	0.34%
UBS Group AG	0.29%
Advisor Group Holdings, Inc.	0.12%
Caitong International Asset Management Co., Limited.	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Universe Pharmaceuticals Inc — free to start.

Data updated 2026-10-19.